Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mutation | 7 | 2024 | 848 | 2.480 |
Why?
|
| Retinal Diseases | 3 | 2024 | 47 | 2.330 |
Why?
|
| Retina | 8 | 2019 | 433 | 1.640 |
Why?
|
| Eye Proteins | 5 | 2020 | 205 | 1.600 |
Why?
|
| Retinitis Pigmentosa | 3 | 2020 | 30 | 1.470 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2016 | 66 | 1.340 |
Why?
|
| Macular Degeneration | 3 | 2016 | 84 | 1.280 |
Why?
|
| Electroretinography | 7 | 2022 | 178 | 1.200 |
Why?
|
| Visual Acuity | 5 | 2020 | 111 | 0.970 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2021 | 57 | 0.840 |
Why?
|
| Scotoma | 2 | 2022 | 6 | 0.830 |
Why?
|
| Visual Fields | 3 | 2019 | 33 | 0.780 |
Why?
|
| Membrane Proteins | 3 | 2016 | 485 | 0.770 |
Why?
|
| Phenotype | 2 | 2022 | 679 | 0.750 |
Why?
|
| RNA Splicing | 1 | 2021 | 9 | 0.740 |
Why?
|
| Inosine Monophosphate | 1 | 2020 | 1 | 0.680 |
Why?
|
| Retinoschisis | 2 | 2018 | 2 | 0.660 |
Why?
|
| Night Vision | 1 | 2019 | 7 | 0.630 |
Why?
|
| Tomography, Optical Coherence | 5 | 2024 | 94 | 0.590 |
Why?
|
| Child | 6 | 2024 | 2242 | 0.560 |
Why?
|
| Retinal Degeneration | 1 | 2019 | 150 | 0.540 |
Why?
|
| Adolescent | 6 | 2024 | 3123 | 0.520 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2016 | 18 | 0.500 |
Why?
|
| Middle Aged | 7 | 2024 | 7164 | 0.480 |
Why?
|
| Synaptosomes | 1 | 2014 | 9 | 0.450 |
Why?
|
| Young Adult | 4 | 2024 | 2731 | 0.430 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2014 | 67 | 0.420 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2014 | 90 | 0.420 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2014 | 126 | 0.400 |
Why?
|
| Adult | 7 | 2024 | 7757 | 0.390 |
Why?
|
| Visual Field Tests | 4 | 2019 | 14 | 0.360 |
Why?
|
| Male | 8 | 2024 | 13487 | 0.320 |
Why?
|
| Humans | 10 | 2024 | 28121 | 0.320 |
Why?
|
| Child, Preschool | 2 | 2024 | 1137 | 0.310 |
Why?
|
| Aged | 5 | 2024 | 5416 | 0.290 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 1461 | 0.260 |
Why?
|
| Genetic Testing | 1 | 2024 | 68 | 0.230 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 82 | 0.220 |
Why?
|
| Animals | 5 | 2021 | 10399 | 0.210 |
Why?
|
| Atrophy | 1 | 2022 | 15 | 0.200 |
Why?
|
| Peripherins | 1 | 2022 | 47 | 0.190 |
Why?
|
| Mice, Knockout | 2 | 2016 | 845 | 0.190 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 1014 | 0.190 |
Why?
|
| Female | 4 | 2024 | 15156 | 0.190 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 19 | 0.180 |
Why?
|
| COS Cells | 1 | 2021 | 49 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 52 | 0.180 |
Why?
|
| Pedigree | 1 | 2020 | 155 | 0.170 |
Why?
|
| IMP Dehydrogenase | 1 | 2020 | 4 | 0.170 |
Why?
|
| Dark Adaptation | 1 | 2019 | 11 | 0.160 |
Why?
|
| Observer Variation | 1 | 2019 | 43 | 0.160 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 49 | 0.150 |
Why?
|
| Disease Progression | 1 | 2020 | 473 | 0.150 |
Why?
|
| Guanidines | 1 | 2017 | 6 | 0.140 |
Why?
|
| Amidines | 1 | 2017 | 8 | 0.140 |
Why?
|
| Benzylamines | 1 | 2017 | 19 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 40 | 0.130 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2016 | 2 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 773 | 0.130 |
Why?
|
| Psychophysics | 1 | 2016 | 10 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 249 | 0.120 |
Why?
|
| Diabetic Retinopathy | 1 | 2017 | 110 | 0.120 |
Why?
|
| Mice | 2 | 2014 | 4645 | 0.110 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 49 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 225 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2014 | 118 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 113 | 0.100 |
Why?
|
| Lipids | 1 | 2014 | 208 | 0.100 |
Why?
|
| Cattle | 1 | 2014 | 389 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 510 | 0.100 |
Why?
|
| Contrast Sensitivity | 1 | 2018 | 3 | 0.040 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2018 | 6 | 0.040 |
Why?
|
| Vitreous Body | 1 | 2017 | 22 | 0.030 |
Why?
|
| Aqueous Humor | 1 | 2017 | 24 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 34 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 2017 | 62 | 0.030 |
Why?
|
| Rabbits | 1 | 2017 | 276 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 152 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 1249 | 0.030 |
Why?
|
| Quality of Life | 1 | 2018 | 491 | 0.030 |
Why?
|